- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03377569
Subcortical Oscillations in Human Sleep Dysregulation
May 10, 2024 updated by: University of Colorado, Denver
Understanding the Role of Subcortical Oscillations in Human Sleep Dysregulation.
Sleep problems are common in the United States (US) adult population (>50 million), and have a negative impact on quality of life, productivity, and healthcare.
A major obstacle to understanding how the brain is involved in human sleep disorders has been the lack of recordings of human brain function, from inside the brain, during the known sleep states.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Sleep is necessary for life; critically important to the regulation of body and brain function.
Sleep problems are common in the U.S. adult population (>50 million), and have a negative impact on quality of life, productivity, and healthcare.
A major obstacle to understanding how the brain is involved in human sleep disorders has been the lack of recordings of brain function, from inside the brain, during the known sleep states; non-rapid eye movement (NREM) and rapid eye movement (REM).
It is very common for patients with Parkinson's disease (PD) to also have sleep disorders, such as insomnia, restless-leg-syndrome and REM-behavior disorder.
One treatment for PD patients is deep brain stimulation (DBS) of the subthalamic nucleus (STN-DBS).
Despite evidence showing that STN-DBS improves several aspects of sleep behavior in PD subjects, few studies have examined the relationship between brain activity and sleep regulation in human subjects.
In this proposal, the investigators will examine sleep in humans by recording brain activity from STN of PD patients who have undergone DBS surgery.
The investigators will also test the hypothesis that STN contributes to both the regulation and disruption of normal sleep behavior.
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with Parkinsons Disease and a documented sleep disorder planning on undergoing bilateral Deep Brain Stimulation surgery at the University of Colorado Hospital.
Description
Inclusion Criteria:
Subjects with Parkinson's Disease (PD) who are planning to have staged, bilateral deep brain stimulation surgery at the University of Colorado Hospital and willing and able to do the following:
- Have a computer and be willing to use it as part of this study.
- Be able to learn to use and maintain a wristband-style sleep monitor.
- Turn off their Implantable Pulse Generator (IPG, implanted battery).
- Wear a wristband-style sleep monitor for 3 weeks, 6 weeks prior to surgery.
- Spend one overnight research stay in the UCH Sleep lab, 3 weeks prior to DBS surgery .
- Spend one overnight research stay in the UCH Sleep lab, immediately prior to IPG surgery, to record brain activity from the DBS electrode .
- Have a 15 minute surgery to externalize the DBS lead cable to allow overnight recordings to occur.
- Be pseudo-randomized to one of 2 conditions: OFF stimulation or ON stimulation.
- Wear a wristband-style sleep monitor for 3 weeks, 3 months post-DBS surgery, in one of the 2 pseudo-randomized conditions.
- Spend one overnight research stay in the UCH Sleep lab, 4 months post DBS surgery, in one of the pseudo-randomized conditions.
Subjects will have a sleep disorder documented in their medical history as determined by a single question screen for REM sleep behavior disorder.
Exclusion Criteria:
- Subjects with Parkinson's Disease (PD) who are not planning to have staged, bilateral deep brain stimulation surgery at the University of Colorado Hospital.
- Subjects without a documented sleep disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group #1
Patients with Parkinsons Disease who will undergo Deep Brain Stimulation surgery.
At home sleep monitoring prior to DBS surgery and in patient polysomnography with neural recording after DBS surgery.
|
Sleep, PD and DBS
|
|
Group #2
Patients with Parkinsons Disease who will undergo Deep Brain Stimulation surgery.
At home sleep monitoring after DBS surgery with DBS stimulation on at night, and in patient polysomnography after DBS surgery.
|
Sleep, PD and DBS
|
|
Group #3
Patients with Parkinsons Disease who will undergo Deep Brain Stimulation surgery.
At home sleep monitoring after DBS surgery with DBS stimulation off at night, and in patient polysomnography after DBS surgery.
|
Sleep, PD and DBS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measuring brain physiological activity via local field potentials and correlation to sleep states (REM, non-REM, etc.)
Time Frame: One entire sleep cycle (each cycle is 8-10 hours).
|
STN LFP activity will be measured by externalized DBS electrodes during in patient polysomnography.
|
One entire sleep cycle (each cycle is 8-10 hours).
|
|
Chronic actigraphy to characterize sleep-wake behavior
Time Frame: 3 weeks
|
The investigators will collect typical sleep-wake behavior-including indirect features of sleep disturbance-by equipping patients with a sleep-monitoring device (ActiGraph AW2) that will record sleep parameters.
|
3 weeks
|
|
Test the functional impact of STN-DBS on sleep-wake behavior through actigraphy
Time Frame: 3 weeks
|
The investigators will examine the impact of STN modulation, via DBS in both On- and Off-Stimulation conditions in separate groups of subjects, on typical sleep-wake behavior.
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: John A Thompson, Ph.D., Principal Investigator
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 27, 2018
Primary Completion (Actual)
August 2, 2020
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
November 29, 2017
First Submitted That Met QC Criteria
December 13, 2017
First Posted (Actual)
December 19, 2017
Study Record Updates
Last Update Posted (Actual)
May 13, 2024
Last Update Submitted That Met QC Criteria
May 10, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-0868
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Sleep, PD and DBS
-
University of ChicagoCompleted
-
Mayo ClinicTerminatedEpilepsy | Parkinson Disease | Neurological DiseaseUnited States
-
University of Alabama at BirminghamNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedParkinson's DiseaseUnited States
-
The Cleveland ClinicAmerican Parkinson's Disease Association, Inc; Beacon BiosignalsRecruitingParkinson DiseaseUnited States
-
University of Alabama at BirminghamNational Institute of Neurological Disorders and Stroke (NINDS)CompletedParkinson's DiseaseUnited States
-
GGZ CentraalUniversity Medical Center Groningen; Maastricht UniversityTerminatedTardive Dyskinesia | Tardive DystoniaNetherlands
-
Insel Gruppe AG, University Hospital BernRecruiting
-
Xuanwu Hospital, BeijingBeijing Pins Medical Co., LtdUnknown
-
Allegheny Singer Research Institute (also known...AbbottRecruitingOpioid-use DisorderUnited States